nitrobenzylthioinosine 5'-monophosphate has been researched along with nsc 352122 in 1 studies
Studies (nitrobenzylthioinosine 5'-monophosphate) | Trials (nitrobenzylthioinosine 5'-monophosphate) | Recent Studies (post-2010) (nitrobenzylthioinosine 5'-monophosphate) | Studies (nsc 352122) | Trials (nsc 352122) | Recent Studies (post-2010) (nsc 352122) |
---|---|---|---|---|---|
32 | 0 | 1 | 16 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agricola, B; Allay, JA; Bonifacino, A; Donahue, RE; Dunbar, CE; Lu, T; Metzger, ME; Persons, DA; Sorrentino, BP | 1 |
1 other study(ies) available for nitrobenzylthioinosine 5'-monophosphate and nsc 352122
Article | Year |
---|---|
Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors.
Topics: Animals; Drug Combinations; Drug Resistance; Genetic Therapy; Genetic Vectors; Glucuronates; Green Fluorescent Proteins; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Luminescent Proteins; Macaca mulatta; Recombinant Proteins; Tetrahydrofolate Dehydrogenase; Thioinosine; Thionucleotides; Transduction, Genetic; Trimetrexate | 2004 |